Stem Cells for Alzheimer’s: What Animal Studies Suggest and Why Human Proof Still Matters
Animal studies suggest MSCs may help Alzheimer’s pathways, but human trials still decide what is real.
Stem-Cell-Derived Dopamine Neurons and Parkinson’s: UCLA’s $9M Environmental Risk Study
UCLA will use stem-cell-derived dopamine neurons to study how pesticides and pollution may affect Parkinson’s risk.
Family-Donor Stem Cells for Epidermolysis Bullosa: Early Trial Results Explained
A pediatric trial reported family-donor MSCs were safe in RDEB and improved symptoms. Here is what the evidence means.
Stem Cell Transplant for MS: What the BEAT-MS Trial Is Testing
The BEAT-MS trial is testing stem cell transplant for treatment-resistant MS. Here is what patients should know.
Stem Cells for Cerebral Palsy: What a New Randomized Trial Actually Found
A new randomized trial studied stem cells for cerebral palsy. Here is what it found, what it did not prove, and why it matters.
Stem Cells for Stroke Recovery: New Study Shows Brain Repair in Mice
Preclinical research shows iPSC-derived neural progenitor cells helped repair stroke injury in mice. Here is what patients should know.
Off-the-Shelf iPSC CAR-T for Lupus: What Fate Therapeutics Reported at ASGCT 2026
Fate reported early Phase 1 data on off-the-shelf iPSC CAR-T for lupus without conditioning chemotherapy.
Stem Cells and Alzheimer’s Disease: What the University of Miami Trial Is Testing
University of Miami is testing whether mesenchymal stem cells can help stabilize early Alzheimer’s decline.
iPSC-Derived Immune Cells From a New Bioreactor: Why 40 Million Macrophages a Week Matters
A new bioreactor method may produce 40 million iPSC-derived macrophages weekly for research and therapy development.
Gene-Edited Stem Cell Transplants for Aggressive Blood Cancers: What the New Trial Shows
New trial data show how gene-edited stem cell transplants may help aggressive AML and MDS treatment.